Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001140361-25-005827
Filing Date
2025-02-25
Accepted
2025-02-25 15:05:03
Documents
1
Effectiveness Date
2025-02-25
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 13134
  Complete submission text file 0001140361-25-005827.txt   14414
Mailing Address 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540
Business Address 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540 609-322-1602
Grace Therapeutics, Inc. (Filer) CIK: 0001444192 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0331
Type: D | Act: 33 | File No.: 021-539175 | Film No.: 25662441
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)